Impact of primary tumor location on efficacy and safety of pembrolizumab (pembro) in patients (pts) with locally advanced or metastatic urothelial carcinoma (UC) enrolled in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-045 trials Meeting Abstract
| Authors: | O'Donnell, P. H.; Balar, A. V.; Castellano, D. E.; De Wit, R.; Vaughn, D. J.; Powles, T.; Vuky, J.; Lee, J. L.; Fradet, Y.; Bellmunt, J.; Fong, L.; Petrylak, D. P.; Gerritsen, W. R.; Quinn, D. I.; Culine, S.; Bajorin, D. F.; Xu, J. Z.; Imai, K.; Moreno, B. H.; Grivas, P. |
| Abstract Title: | Impact of primary tumor location on efficacy and safety of pembrolizumab (pembro) in patients (pts) with locally advanced or metastatic urothelial carcinoma (UC) enrolled in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-045 trials |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900523 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.516 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 516 -- Meeting was conducted online as well as in person -- Source: Wos |
